ATS 2025 Conference Highlights
Choose your experience from the options below
Unlock the Conference, Anytime, Anywhere
Revisit the key moments of ATS 2025. Access all the inspiring presentations, valuable clinical insights, and presentations from pulmonary, critical care, and sleep sessions with our ATS Conference Highlight packages. Check out the package options below and pick the one that's right for you.
Learn at your own pace, whenever and wherever you are.
On Demand content available 24-48 hours after each session.
Add-On to In-Person Conference Registration
$50 member
Access equivalent to the All Access Pass package
CME is not available for on demand sessions.
Abstracts Package
$439 member
On Demand access to 30+ Abstract Sessions (Mini Symposia, RAPiD Poster Discussion Sessions)
Access to ePosters
On Demand access to Keynote Series
Access to livestreaming
Bookmark sessions and browse abstracts
Network (Send connection requests, follow, and explore our extensive network of attendees)
Browse Exhibitors
On Demand access to Industry Programming
Post Conference Webinars
Accessible until March 2026
CME is not available for on demand sessions.
View complete list of sessions
×
Livestream
On Demand
K1 PROVIDING HEALTH CARE FOR UNHOUSED INDIVIDUALS A3 FELLOWS CASE CONFERENCE A14 ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF ILD A15 PRIMARY AND SECONDARY RESULTS FROM CLINICAL TRIALS: COPD AND PLEURAL DISEASE A17 TUBERCULOSIS: STILL KICKING, STILL HIDING - SCIENCE, SPREAD, AND WHAT WE’RE DOING ABOUT IT A18 BEST TRIALS IN PULMONARY REHABILITATION A28 DEEPER DIVES, GREATER IMPACT: LEVERAGING SECONDARY ANALYSES IN CRITICAL CARE TRIALS A31 THE EVOLVING LANDSCAPE OF BRONCHOPULMONARY DYSPLASIA: MAKING STRIDES A82 BREAKING NEWS: 2025 CLINICAL TRIAL RESULTS IN PULMONARY MEDICINE A83 GREAT CASES: CLINICAL, RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER CLINICIANS A95 NEW AND EXCITING BIOMARKERS IN ILD A96 ADVANCES IN COPD A97 FROM SURVIVING TO THRIVING: UNDERSTANDING AND IMPROVING LONG TERM OUTCOMES AFTER CRITICAL ILLNESS A100 REIMAGINING RELIEF: ADVANCES IN PHARMACOTHERAPY AND NERVE STIMULATION FOR SLEEP APNEA TREATMENT A109 SMOKE, SNOOZE, AND ICU BLUES: THE INFLUENCE OF ENVIRONMENTAL EXPOSURES AND CRITICAL CARE CONDITIONS ON SLEEP A110 MECHANISMS OF LUNG TUMORIGENESIS, TRANSITION AND TARGETED THERAPEUTICS B16 SUBPHENOTYPING ARDS: FROM THE WHOLE PERSON DOWN TO THE CELL B17 THE POWER OF TEAM SCIENCE: INTERDISCIPLINARY APPROACHES TO PULMONARY AND CRITICAL CARE B18 BEST IN PEDIATRICS B19 ON LOMBARD STREET: CELLULAR PATHOPHYSIOLOGY OF PULMONARY VASCULAR DISEASE: FROM EPIGENETIC AND MOLECULAR DRIVERS TO TREATMENT TARGETS B20 NTM, BRONCHIECTASIS, AND THE QUEST TO UNDERSTAND: A STORY OF LUNGS AND LOVE B26 ORACLE PARK: VASCULAR ABNORMALITIES, RISK STRATIFICATION, AND CLINICAL MANAGEMENT OF PULMONARY HYPERTENSION B14 FROM INFLAMMATION TO INFECTION: EXPLORING BREAKTHROUGHS IN AIRWAYS DISEASE B93 COPD EPIDEMIOLOGY AND MANAGEMENT B94 UNRAVELING THE CODE OF ENVIRONMENTAL EXPOSURE: RESPONSE WITH EPIGENETICS AND OMICS B96 CROSSING THE GOLDEN GATE BRIDGE: CLINICAL TRIALS, TARGETED THERAPIES AND NOVEL APPROACHES IN PULMONARY ARTERIAL HYPERTENSION B97 IT'S A VIRUS PARTY! FLU, PARAINFLUENZA, RSV, COVID, AND A LITTLE HIVv< li>B98 CELLULAR INTERACTIONS AND SIGNALING NETWORKS IN PULMONARY FIBROSIS B100 REVOLUTIONIZING NODULE MANAGEMENT AND LUNG CANCER DIAGNOSIS: FROM PREDICTIVE MODELS TO ADVANCED INTERVENTIONS B102 MEDICAL EDUCATION IN PULMONARY AND CRITICAL CARE MEDICINE B107 WHAT'S NEW IN PULMONARY REHABILITATION ASSESSMENT STRATEGIES? C3 PEDIATRIC CLINICAL CHEST ROUNDS C14 STRENGTHENING YOUR "-ABS": CLINICAL THERAPEUTICS FOR INFLAMMATORY LUNG DISEASE C15 OMICS ODYSSEY ACROSS LUNG DISEASES C17 DELIRIUM, DISPARITIES, AND DISABILITY: ADVANCING EQUITY IN CRITICAL ILLNESS OUTCOMES C19 UNCOVERING DEEP ROOTS: NEW MECHANISMS IN AIRWAY DISEASE C20 CROSSING THE GOLDEN GATE: INNOVATIVE OSA TREATMENT TRIALS AND CARDIOVASCULAR OUTCOMES C26 SMOKE, HEAT, AND HEALTH: LUNG DISEASE IN THE AGE OF CLIMATE CHANGE AND WILDFIRES C28 TB, NTM, AND PNEUMONIA: THE RESPIRATORY TRIO YOU DIDN’T INVITE TO THE PARTY C94 BREATHING EASY: UNRAVELING THE MYSTERIES OF ASTHMA THROUGH TRANSLATIONAL STUDIES C96 SEPSIS SCIENCE: OPTIMIZING PERSONALIZATION AND PROCESS C97 CUTTING-EDGE ADVANCES IN PEDIATRIC LUNG DISEASES: FROM PREDICTION TO MANAGEMENT C98 PALACE OF FINE ARTS: INNOVATIVE THERAPEUTIC APPROACHES AND SURVIVAL PREDICTION IN PULMONARY HYPERTENSION C100 MORNING SHOWS THE DAY: PERINATAL DETERMINANTS OF AIRWAY STRUCTURE AND FUNCTION C105 UPDATES ON MONITORING AND TREATMENT OF PEDIATRIC LUNG DISEASES ACROSS THE GLOBE D13 CURRENT RESEARCH IN CRITICAL AND ACUTE CARE D14 LESSONS FROM CLINICAL STUDIES IN COPD D16 INDOOR/OUTDOOR AIR POLLUTION: UNCOVERING DISPARITIES AND ADVANCING LUNG HEALTH D91 IMAGING-BASED ADVANCES IN FIBROTIC ILD D92 BIOMARKERS AND PREDICTIVE TOOLS IN COPD D93 SUPPORTING LIFE AROUND THE GLOBE: OXYGEN, VENTILATION, AND CARDIAC ARREST SCIENCE D94 INROADS INTO NOVEL THERAPEUTICS AND DELIVERY APPROACHES FOR PEDIATRIC LUNG DISEASES D98 TRACING THE SCAR IN INTERSTITIAL LUNG DISEASES
Symposia Package
$439 member
On Demand access to scientific symposia including but not limited to: Clinical Year in Review, Pediatric Year in Review, Keynote Series, Adult Clinical Core Curriculum, Pediatric Clinical Core Curriculum, Great Cases: Clinical, Radiologic, and Pathologic Correlations by Master Clinicians, Fellows Case Conference, Pediatric Clinical Chest Round, Late Breaking Clinical Trial Symposium, AJRCCM, JAMA, NEJM Discussions on the Edge: Critical Care and Pulmonary Research Journal Sessions.
Access to livestreaming
Bookmark sessions and access to ePosters
Network (Send connection requests, follow, and explore our extensive network of attendees)
Browse Exhibitors
On Demand access to Industry Programming
Post Conference Webinars
Accessible until March 2026
CME is not available for on demand sessions.
View complete list of sessions
All Access Pass
$560 member
Access to both Abstract and Scientific Symposia ATS 2025 Conference Highlight packages, including ePosters
Accessible until March 2026
CME is not available for on demand sessions.
